P-glycoprotein

P-糖蛋白 (P-gp) 又称多药耐药蛋白 1 (MDR1),是一种重要的细胞膜蛋白,可将许多外来物质泵出细胞。更正式地说,它是一种具有广泛底物特异性的 ATP 依赖性外排泵。P-gp 广泛分布和表达于肠上皮中,它将外来化合物(如毒素或药物)泵回肠腔,在肝细胞中,它将它们泵入胆管,在肾近端小管细胞中,它将它们泵入尿管,在构成血脑屏障和血睾屏障的毛细血管内皮细胞中,它将它们泵回毛细血管。一些癌细胞也表达大量 P-gp,这使得这些癌症具有多药耐药性。P-gp 是一种具有广泛底物特异性的 ATP 依赖性外来化合物药物外排泵。它负责减少耐多药细胞中的药物积累,并经常介导对抗癌药物的耐药性的发展。这种蛋白质还充当血脑屏障中的转运蛋白。

P-glycoprotein (P-gp) also known as multidrug resistance protein 1 (MDR1) is an important protein of the cell membrane that pumps many foreign substances out of cells. More formally, it is an ATP-dependent efflux pump with broad substrate specificity. P-gp is extensively distributed and expressed in the intestinal epithelium where it pumps xenobiotics (such as toxins or drugs) back into the intestinal lumen, in liver cells where it pumps them into bile ducts, in the cells of the proximal tubular of the kidney where it pumps them into urine-conducting ducts, and in the capillary endothelial cells comprising the blood–brain barrier and blood-testis barrier, where it pumps them back into the capillaries. Some cancer cells also express large amounts of P-gp, which renders these cancers multi-drug resistant. P-gp is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood–brain barrier.

共 2种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
BDP 650/665 X NHS ester

BDP 650/665 X NHS ester 是一种靶向 P-糖蛋白 (P-gp/ABCB1/MDR1) 的荧光探针,可实现对肿瘤细胞中 P-gp 的选择性检测与定量分析,也可与脂质偶联以标记纳米颗粒,这些标记的纳米颗粒在多种处理过程中均能保持稳定,并适用于体外及体内模型(如胶质母细胞瘤)中纳米颗粒分布与细胞摄取的可视化研究,是研究多药耐药性癌症及体外肿瘤细胞模型中 P-gp 表达情况的有力工具。

1616842-78-4
Ligand
98.53%
BDP 650/665 X NHS ester
TASP0434299

TASP0434299 (Compound 10) 是一种血管加压素 V1b 受体标记配体,对人源和鼠源 V1B 受体具有高结合亲和力(IC50 分别为 0.526 nM 和 0.641 nM),并对人源 V1B 受体表现出强效拮抗活性(IC50 为 0.639 nM),同时是人源和恒河猴 P-糖蛋白 (P-glycoprotein) 的底物,导致恒河猴脑摄取量较低,可在体外和体内以饱和且特异性的方式与大鼠和猴垂体组织中的 V1B 受体结合,经氚或 11C 放射性标记后可作为原型 V1B receptor 放射性配体,通过正电子发射断层扫描技术实现麻醉猴垂体 V1B receptor 的可视化。

1520893-08-6
Ligand
TASP0434299

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础